H. Rudiger et al., Medicinal chemistry based on the sugar code: Fundamentals of lectinology and experimental strategies with lectins as targets, CURR MED CH, 7(4), 2000, pp. 389-416
Theoretical calculations reveal that oligosaccharides are second to no othe
r class of biochemical oligomery in terms of coding capacity. As integral p
art of cellular glycoconjugates they can serve as recognitive units for rec
eptors (lectins). Having first been detected in plants, lectins are present
ubiquitously. Remarkably for this field, they serve as bacterial and viral
adhesins. Following a description of these branches of lectinology to illu
strate history, current status and potential for medicinal chemistry, we do
cument that lectins are involved in a wide variety of biochemical processes
including intra- and intercellular glycoconjugate trafficking, initiation
of signal transduction affecting e.g. growth regulation and cell adhesion i
n animals. It is thus justified to compare crucial carbohydrate epitopes wi
th the postal code ensuring correct mail routing and delivery. In view of t
he functional relevance of lectins the design of high-affinity reagents to
occupy their carbohydrate recognition domains offers the perspective for an
attractive source of new drugs. Their applications can be supposed to enco
mpass the use as cell-type-selective determinant for targeted drug delivery
and as blocking devices in anti-adhesion therapy during infections and inf
lammatory disease. To master the task of devising custom-made glycans/glyco
mimetics for this purpose, the individual enthalpic and entropic contributi
ons in the molecular rendezvous between the sugar receptor under scrutiny a
nd its ligand in the presence of solvent molecules undergoing positional re
arrangements need to be understood and rationally exploited. As remunerativ
e means to this end, cleverly orchestrated deployment of a panel of methods
is essential. Concerning the carbohydrate ligand, its topological paramete
rs and flexibility are assessed by the combination of computer-assisted mol
ecular-mechanics and molecular-dynamics calculations and NMR-spectroscopic
measurements. In the presence of the receptor, the latter technique will pr
ovide insights into conformational aspects of the bound ligand and into spa
tial vicinity of the ligand to distinct side chains of amino acids establis
hing the binding site in solution. Also in solution, the hydrogen-bonding p
attern in the complex can be mapped with monodeoxy and monofluoro derivativ
es of the oligosaccharide. Together with X-ray crystallographic and microca
lorimetric studies the limits of a feasible affinity enhancement can be sys
tematically probed. With galactoside-binding lectins as instructive model,
recent progress in this area of drug design will be documented, emphasizing
the general applicability of the outlined interdisciplinary approach.